Charles Elliott Sigal - Director, Adaptimmune Therapeutics Plc
As of July 2, 2021
Charles Elliott Sigal Net Worth
- Net worth is estimated to be at least $1.71M
- Owns at least 367,038 units of Adaptimmune Therapeutics Plc stock
Charles Elliott Sigal Trading
- Largest purchase of shares was 45,000 units , worth over $68.7K on May 18, 2016
- In total has made about 8 transactions over 5 years
- Usually trades in July, with the busiest year in 2016
Charles Elliott Sigal
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||
Charles Elliott Sigal Mailing Address
- Mailing address is 32 Brearly Road Princeton NJ 08540 NJ
Adaptimmune Therapeutics Plc Executive Compensation
Name |
Year
|
Salary
|
Option Awards
|
Other Earnings Plans or Compensations
|
Other Compensation
|
Total
|
|---|---|---|---|---|---|---|
| Adrian Rawcliffe | 2020 | $574,000 | $1,715,346 | $378,840 | $33,416 | $2,701,602 |
| Adrian Rawcliffe | 2019 | $500,481 | $1,427,399 | $177,251 | $49,912 | $2,155,042 |
| Adrian Rawcliffe | 2018 | $457,011 | $730,791 | $174,807 | $54,775 | $1,417,384 |
| Gavin Wood | 2020 | $337,065 | $990,268 | $166,847 | $73,731 | $1,567,911 |
| Helen Tayton-Martin | 2020 | $454,940 | $857,661 | $225,195 | $23,531 | $1,561,327 |
| Helen Tayton-Martin | 2019 | $435,949 | $766,900 | $137,324 | $30,491 | $1,370,664 |
| Helen Tayton-Martin | 2018 | $408,308 | $730,791 | $156,178 | $22,007 | $1,317,284 |
| William Bertrand | 2020 | $443,456 | $857,661 | $219,511 | $30,485 | $1,551,113 |
| William Bertrand | 2019 | $432,640 | $766,900 | $136,282 | $35,358 | $1,371,180 |
| William Bertrand | 2018 | $416,000 | $685,114 | $159,120 | $35,070 | $1,295,304 |
| John Lunger | 2020 | $400,000 | $857,661 | $198,000 | $31,802 | $1,487,463 |
| John Lunger | 2019 | $366,867 | $435,546 | $94,542 | $35,655 | $932,610 |
| John Lunger | 2018 | $316,958 | $602,909 | $92,948 | $35,07 | $1,047,885 |
| Michael Garone | 2020 | $217,000 | - | - | - | $217,000 |
| Michael Garone | 2019 | $206,500 | - | - | - | $206,500 |
| No matching records found | ||||||
Source: https://www.sec.gov/Archives/edgar/data/1621227/000110465921047833/tm212433-2_def14a.htm
Adaptimmune Therapeutics Plc Insider Trading
- The most recent transaction was 2,939 units sold on August 2, 2021 by John Lunger worth over $10.54K
- In the last 5 years, insiders at Adaptimmune Therapeutics Plc sold an estimated value of $39.87M and bought an estimated value of $526.76M
- The most active traders are Adrian Rawcliffe, Chief Executive Officer, David M Mott, Director, and John Lunger, Chief Patient Supply Officer
- Insider trading is most common in January, with the busiest year in 2018
Adaptimmune Therapeutics PLC Insider Trades
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||